GF Fund Management
DGX icon

GF Fund Management’s Quest Diagnostics DGX Stock Holding History

GF Fund Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$710K Hold
3,048
– – 0.01% 198
2026
Q2 		$646K Buy
3,048
+32
+1% +$6.28K 0.01% 203
2026
Q1 		$591K Hold
3,016
– – 0.01% 211
2025
Q4 		$523K Sell
3,016
-55
-2% -$10K 0.01% 224
2025
Q3 		$585K Buy
3,071
+298
+11% +$52.9K 0.01% 217
2025
Q2 		$498K Sell
2,773
-20
-0.7% -$3.47K 0.01% 254
2025
Q1 		$473K Hold
2,793
– – 0.01% 259
2024
Q4 		$421K Buy
+2,793
New +$434K 0.01% 239

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Davis Selected Advisers
Davis Selected Advisers Tucson, Arizona $23.2B AUM 18.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

GF Fund Management's DGX Position: Q3 2026 in Review

GF Fund Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 3,048 shares worth $710K. The position accounts for 0.01% of the portfolio, ranked #198.

GF Fund Management first reported a position in DGX in Q4 2024 and has held it in 8 quarters since. 722 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • GF Fund Management held 3,048 shares of Quest Diagnostics worth $710K as of Q3 2026.
  • GF Fund Management left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up 0.01% of GF Fund Management's portfolio in Q3 2026, its #198 holding.
  • GF Fund Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 8 quarters since.
  • 722 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.